Noninferiority Study Comparing the Efficacy and Safety of a New Hyaluronic Acid ( HA ) Filler Containing Lidocaine With an Existing HA Filler for the Treatment of Nasolabial Fold Wrinkles: A Randomized, Double‐Blind, Split‐Face Trial
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70309 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Ji Young Cho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Hyaluronic Acid, Skin Aging, Dermal Fillers, Lidocaine. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ExoCoBio Inc..
Abstract (Originalsprache)
Background
The aesthetic use of hyaluronic acid (HA) has led to the development of various commercial HA fillers. Crosslinked HA dermal fillers are commonly used to treat facial wrinkles. This study demonstrated the non‐inferiority of the newly developed hyaluronic acid filler by comparing its efficacy and safety to that of the existing hyaluronic acid filler.
Methods
This 48‐week study was designed as a randomized, double‐blind, split‐face trial. Subjects who met the inclusion and exclusion criteria had a total of four follow‐up visits after receiving a dermal filler in the nasolabial folds. Efficacy was assessed using the Wrinkle Severity Rating Score (WSRS) and the Global Aesthetic Improvement Scale (GAIS). Safety was determined through the evaluation of laboratory tests, monitoring adverse events, and verifying vital signs.
Results
WSRS measured at week 24 of the follow‐up visit showed no statistically significant difference, with scores of 2.02 ± 0.71 in the new filler group and 2.27 ± 0.68 in the existing filler group. Even at the 48‐week follow‐up visit, the improvement rate in the Wrinkle Severity Rating Scale (WSRS) of more than 1 point did not show a statistically significant difference between the new filler group and the existing filler group. The GAIS scores at each follow‐up visit showed no statistically significant differences between the two groups. The most frequently reported symptoms related to the test device during the 48‐week trial were pain and swelling. However, these symptoms were not statistically significant when compared to the control group from a treatment perspective.
Conclusions
In a 48‐week clinical trial aimed at treating nasolabial fold (NLF) wrinkles, the new hyaluronic acid (HA) filler demonstrated efficacy and safety comparable to that of existing control filler. As a result, the new HA filler is both an effective and safe option for improving NLF wrinkles. Trial Registration This study was registered with ClinicalTrials.gov under the registration number NCT06310863
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Plastic and Reconstructive Surgery, Nowon Eulji Medical Center, School of Medicine, Eulji University, Seoul, Korea.
- Department of Plastic and Reconstructive Surgery, Sanggye Paik Hospital, School of Medicine, Inje University, Seoul, Korea.
ORCID-Profile: Ji Young Cho, Jong Hun Lee
Förderung
- ExoCoBio Inc.
Zitieren
APA
Cho, J. Y., Kim, S. H., Cho, H., Park, Y., Yang, H. J., An, J. S., Won, C. H., & Lee, J. H. (2025). Noninferiority Study Comparing the Efficacy and Safety of a New Hyaluronic Acid ( HA ) Filler Containing Lidocaine With an Existing HA Filler for the Treatment of Nasolabial Fold Wrinkles: A Randomized, Double‐Blind, Split‐Face Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70309
Vancouver
Cho JY, Kim SH, Cho H, Park Y, Yang HJ, An JS, et al. Noninferiority Study Comparing the Efficacy and Safety of a New Hyaluronic Acid ( HA ) Filler Containing Lidocaine With an Existing HA Filler for the Treatment of Nasolabial Fold Wrinkles: A Randomized, Double‐Blind, Split‐Face Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70309
BibTeX
@article{Cho2025,
author = {Cho, Ji Young and Kim, Seung Hyeon and Cho, Hyesoo and Park, Yoonjae and Yang, Hee Joo and An, Jee Soo and Won, Chong Hyun and Lee, Jong Hun},
title = {Noninferiority Study Comparing the Efficacy and Safety of a New Hyaluronic Acid ( HA ) Filler Containing Lidocaine With an Existing HA Filler for the Treatment of Nasolabial Fold Wrinkles: A Randomized, Double‐Blind, Split‐Face Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70309}
}
EUVIMED